DURECT Corp declares sale of 4.44m shares of common stock

Posted on: Mon, 14 Sep 2009 06:08:00 EDT


Symbols: DRRX
Sep 14, 2009 (M2 EQUITYBITES via COMTEX) --
DRRX | Quote | Chart | News | PowerRating -- Speciality pharmaceutical company DURECT Corp (Nasdaq:DRRX) declared on
Friday the sale of 4,444,444 primary shares of common stock.

The agreement was executed with affiliates of Venrock, a premier
venture capital firm.

The financing was priced at USD2.25 per share for net proceeds of
approximately USD10m to DURECT.

The financing is expected to be concluded on or about 18 September 2009
subject to customary closing conditions.

Comments on this story may be sent to admin@m2.com

For full details on Durect Corporation (DRRX) DRRX. Durect Corporation (DRRX) has Short Term PowerRatings at TradingMarkets. Details on Durect Corporation (DRRX) Short Term PowerRatings is available at This Link.

UPCOMING EVENTS
Learn new strategies, how to trade in this market, and the stocks you should be focusing on each day. Join us for our free 20 minute tele-seminars during the week.
Thursday February 11 04:30 PM
* Attendance is strictly limited and are filled on a first-come, first-served basis.